Immunotherapy 3.0: Breakthroughs Steering the Next Generation of Cancer Control

Area of Science:

• Hematology
• Public Health
• Health Systems Strengthening

Background:

• Hematologic disorders represent a growing health challenge across Africa, exacerbated by systemic constraints in diagnostics, specialist workforce, blood transfusion services, and medicine access.
• These challenges lead to delayed diagnoses, suboptimal treatment, and poor patient outcomes, highlighting an urgent need for improved care frameworks.

Purpose of the Study:

• To review current evidence on diagnostic and therapeutic gaps in hematology care within the African context.
• To examine emerging strategies and innovations aimed at strengthening equitable and sustainable hematology services across the continent.

Main Methods:

• This narrative review synthesizes existing evidence on the state of hematology care in Africa.
• It examines progress in laboratory strengthening, point-of-care diagnostics, access to therapies, and innovative service delivery models.

Main Results:

• Initiatives like point-of-care testing and regional labs have improved early diagnosis of sickle cell disease and hematologic malignancies in several African nations.
• Access to essential therapies and innovations in blood transfusion services show progress, though coverage remains uneven and workforce shortages persist.
• Capacity-building efforts through international collaborations are expanding training and teleconsultation, but face persistent financial and supply chain barriers.

Conclusions:

• Transforming hematology care in Africa necessitates coordinated, system-level strategies encompassing diagnostics, therapies, blood transfusion, workforce development, and digital health.
• Sustainable progress hinges on enhanced health system financing, regional manufacturing, regulatory support, and context-sensitive research.
• A shift towards integrated, patient-centered hematology care frameworks is essential to reduce morbidity and mortality and improve outcomes for blood disorders and cancers continent-wide.